Drug’s Safety Questioned for Gestational Diabetes

Drug’s Safety Questioned for Gestational Diabetes

Newborns of mothers who took glyburide to treat gestational diabetes mellitus needed neonatal intensive care more often than infants whose mothers were on insulin therapy for gestational diabetes, according to a study published in JAMA Pediatrics. While the report has not yet triggered an FDA inquiry into whether the medication should be contraindicated in pregnancy, researchers recommended further study into the matter.

Read the source article at Insulin NationHome